-
On 16 July 2020, the Court of Justice of the European Union (CJEU) issued a judgment in the so-called “Schrems II” case (case C-311/18, see full text and press release), which will have a significant impact on transferring personal data outside the EU and the EEA. The decision is likely to cause some uncertainty and […]
-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
Need ‒ and room ‒ for more than “DoctorOnline” and “Telemedica” While the main challenge to the healthcare system has recently been COVID-19, this does not mean that other healthcare challenges have ceased to exist in our society. Stay-at-home orders have raised the issue of remote medical check-ups and consultations. This has led to more […]
-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
On 17 March 2020 the Cabinet of Ministers adopted new amendments to Cabinet Regulation No. 416 “Procedures Regarding the Distribution and Quality Control of Medicinal Products”. The amendments came into force on 31 March 2020. However, some of them will be coming into force later, by 1 July 2021 latest. The amendments are aimed at […]
-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
On 6 February 2020, the Latvian parliament (the Saeima) adopted a new Trade Marks Law at the third and final reading. The law entered into force on 6 March 2020. Our contribution During the drafting of the new law, some initiatives proposed by our Latvia office partner, sworn attorney Andris Tauriņš, were implemented in the […]
-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Latvia specifically targeted at Life Sciences companies. The government has issued an order limiting export of pharmaceuticals necessary for treatment of Covid-19. The State Medicines Agency will publish a list of pharmaceuticals on its website based […]
